Particle.news

Business ❯Pharmaceuticals ❯AbbVie ❯Pipeline

Neuroscience Diseases

AbbVie Acquires Neuroscience Biotech Cerevel for $8.7 Billion

Terms of Service Privacy Policy Jobs Help Partners About Us

Copyright © 2025 Mina Labs Inc.